Peptide Therapy:
Restore Cellular Energy, Metabolism, and Performance at the Source
Declining mitochondrial function is one of the recognized hallmarks of biological aging.1
Mitochondria are the energy centers inside nearly every cell. They control how efficiently your body converts food into fuel, how well you respond to exercise, how quickly you recover, and how resilient you feel under stress. Loss of mitochondrial function has been linked to fatigue, exercise intolerance and muscle weakness, and to the disability that develops with age.2
MOTS-c is a mitochondrial-derived peptide that acts as a metabolic signal between mitochondria and the rest of the cell.3
MOTS-c is a naturally occurring peptide your body already produces.4 In laboratory and animal studies, it acts as a metabolic messenger that regulates insulin sensitivity and metabolic homeostasis, in part through AMPK activation.4
Circulating MOTS-c levels have been reported to be lower in older people and in people with type 2 diabetes. Whether lower MOTS-c causes slower metabolism or reduced exercise response in humans has not yet been established.56
In older mice, MOTS-c treatment increased physical capacity; comparable benefits have not yet been shown in human clinical trials. However, anecdotally, positive patient outcomes are noted.78
Patients enrolled in our EnergizeMe mitochondrial optimization program may experience:
I finally have energy that lasts all day — no crash, no caffeine.
Sustained Energy Without Stimulants — MOTS-c is not a stimulant. Its effect on day-to-day energy levels has not yet been tested in human clinical trials, and individual experiences vary.
My body is finally burning fat again — not just storing it.
Smarter Fat Utilization — In cell and mouse studies, MOTS-c activates AMPK, a key metabolic regulator, and it prevented diet-induced obesity in mice. Effects on body composition in people have not yet been established in clinical trials. Anecdotally, though, patients do report positive outcomes.4
I’m not exhausted after every meal the way I used to be.
Improved Insulin Sensitivity — In mice, MOTS-c treatment prevented age-related and diet-induced insulin resistance, and lower circulating MOTS-c has been observed in people with type 2 diabetes. Whether MOTS-c treatment improves blood sugar control in people has not yet been shown in clinical trials.45
My workouts feel different — I’m stronger, and I’m not wiped out the next day.
Better Exercise Response & Recovery — In mice of different ages, MOTS-c enhanced physical performance, and in humans, exercise itself raises MOTS-c levels in muscle and blood. The effects of MOTS-c treatment on strength, endurance or recovery in people have not yet been tested in clinical trials. However, anecdotally, positive patient outcomes are noted.7
The brain fog is lifting. I feel sharp in a way I haven’t in years.
Cognitive Clarity & Stress Resilience — The brain is one of the most metabolically active organs in the body. The effects of MOTS-c on focus, mental fatigue or stress resilience have not yet been studied in human clinical trials. Anecdotally, though, patients do report positive outcomes.
I’m not losing muscle the way I was. My body is holding onto what I’ve built.
Preservation of Lean Muscle Mass — Impaired muscle mitochondrial function is recognized as a major contributor to sarcopenia — the gradual loss of muscle mass and function with age — and in cell and mouse studies, MOTS-c reduced myostatin and muscle-atrophy signaling. Whether MOTS-c preserves muscle in people is not yet known. However, anecdotally, positive patient outcomes are noted.910
MOTS-c may be right for you if:
This program is often combined with structured nutrition, movement guidance, and lifestyle optimization for the best results. Dr. Varano or a member of his Medical Provider Team will review your full picture before recommending a protocol.
Our EnergizeMe program is designed as a monthly metabolic optimization pathway. Every protocol is a physician-designed protocol.
$599
Your journey begins with a comprehensive evaluation — reviewing your symptoms, health history, labs, and metabolic markers. This assessment identifies where your mitochondrial and metabolic function currently stands and establishes your personalized protocol starting point.
$279/month
Membership gives you the continuous oversight and support that makes peptide therapy work. Dr. Varano and the team monitor your protocol, make adjustments as needed, and remain accessible throughout your program.
Two ways to start — and one powerful upgrade when you’re ready for it.
Month 4 — Add SS-31 On Your Terms:
When you reach Month 4 of your cycle, you have the option to add a 16-day SS-31 protocol. SS-31 binds cardiolipin in the inner mitochondrial membrane; whether adding it to MOTS-c improves results has not yet been studied.
SS-31 Add-On in Month 4 (pricing discussed at your assessment)
The preferred stacking protocol — MOTS-c and SS-31 working together as a structured, fully managed mitochondrial optimization program.
Why stack MOTS-c with SS-31?
MOTS-c is a mitochondrial-derived signaling peptide, while SS-31 binds cardiolipin in the inner mitochondrial membrane. They act by different mechanisms, but the combination has not yet been studied in clinical trials and a greater benefit than either alone has not yet been shown.
MOTS-c is a naturally occurring mitochondrial-derived peptide that regulates how the body produces and uses energy. In animal studies, MOTS-c treatment improved insulin sensitivity and physical performance. These effects have not yet been confirmed in human clinical trials. Anecdotally, though, patients do report positive outcomes.47
MOTS-c is not an appetite suppressant or a stimulant. It is a signaling peptide whose metabolic effects have so far been shown mainly in cell and animal studies. Weight or body-composition changes with MOTS-c have not yet been demonstrated in human clinical trials, and it is not a weight-loss drug.48
MOTS-c may be considered for patients experiencing fatigue, metabolic slowdown, exercise resistance, insulin sensitivity issues, or age-related declines in energy and recovery, although its benefit in these groups has not yet been established in human trials. However, anecdotally, positive patient outcomes are noted. It is well-suited for anyone seeking a longevity-focused, foundational approach to metabolic health.
There are no human clinical trial data on how quickly MOTS-c works, and responses vary between individuals. Metabolic and body composition changes typically develop over time. Results vary based on baseline health, activity level, nutrition, and adherence to your overall program.
SS-31 (Elamipretide) is a mitochondria-targeted peptide that binds cardiolipin in the inner mitochondrial membrane. MOTS-c is a mitochondrial-derived signaling peptide. The two act by different mechanisms; their combination has not yet been studied in clinical trials.11 SS-31 is part of the EnergizeMe Suite.
SS-31 is administered as a 16-day treatment protocol and is available up to 3 times per year. It can be added to your Standard EnergizeMe plan in Month 4 (pricing discussed at your assessment), or included automatically in every cycle under the Premium EnergizeMe Stack at $275/month.
Growth hormone secretagogues like Sermorelin and CJC-1295 + Ipamorelin work by stimulating the pituitary gland to produce more growth hormone — supporting muscle, recovery, body composition, and sleep quality. MOTS-c works differently: it is a mitochondrial-encoded signaling peptide that improved insulin sensitivity and metabolic homeostasis in animal studies.4 Think of MOTS-c as restoring your cellular power plants; growth hormone peptides as boosting your body’s master recovery signal. Some patients benefit from both, depending on their goals.
Human safety data for MOTS-c are very limited: the FDA states it has not identified human exposure data for drug products containing MOTS-c and lacks important information about its safety.128 MOTS-c has not been studied in pregnancy or breastfeeding and should not be used during either. Dr. Varano will review your full medical history and any medications before recommending this therapy.
Results are enhanced when MOTS-c therapy is paired with regular physical activity, balanced nutrition, adequate sleep, and lifestyle optimization. Your program includes guidance to support these areas.
Yes. MOTS-c is offered exclusively within the YoungerMeMD membership model to ensure proper medical oversight, continuous monitoring, and long-term optimization. Membership is required for all peptide therapy programs.
At YoungerMeMD, peptide therapy is treated as real medicine — because it is. Every MOTS-c and SS-31 prescription is sourced exclusively from fully vetted, state-licensed 503A compounding pharmacies that meet the highest standards for sterility, potency, and consistency.
Our peptides are never labeled “for research purposes.” They are compounded for prescription clinical use only, prepared under strict safety protocols, and dispensed with full clinician oversight. Compounded peptides are not FDA-approved drugs, and MOTS-c remains investigational: the FDA lists it among bulk drug substances that may present significant safety risks when used in compounding.12
What this means for patients:
By partnering only with top-tier compounding pharmacies, we protect the integrity of your peptide journey and ensure therapies like MOTS-c and SS-31 are prepared to consistent quality standards and prescribed with clinical oversight.
Energy is the foundation of everything.
When your mitochondria aren’t firing efficiently, nothing else works as well as it should — not your hormones, not your recovery, not your mental clarity. EnergizeMe is designed to support mitochondrial health; it has not yet been shown to improve the results of other therapies.
Most patients combine EnergizeMe with:
Think of MOTS-c as the foundation your other therapies build on.
EnergizeMe Suite — Stack Options
MOTS-c builds your metabolic foundation. These programs are designed to work alongside it — each one targeting a different dimension of performance, recovery, and longevity.
MOTS-c restores mitochondrial signaling and metabolic communication. SS-31 works differently — it binds cardiolipin in the inner mitochondrial membrane and, in preclinical studies, protects mitochondrial structure. Whether the combination adds benefit has not yet been studied in clinical trials.11 This is the preferred stacking protocol for patients who want the most complete mitochondrial optimization available.
Two Ways to Add SS-31
Option A — Add On Your Terms
Pricing discussed at your assessment
16-day SS-31 protocol added to your $225/month standard plan in Month 4 of your cycle. Available up to 3x per year. You decide when.
Option B — Premium Managed Stack Most Popular
$275/month
3 months MOTS-c + 16-day SS-31 in Month 4, every cycle. Fully managed and monitored by Dr. Varano. $50 more per month — SS-31 timing handled for you.
Growth hormone secretagogues like CJC-1295 + Ipamorelin and Sermorelin work differently than MOTS-c — stimulating the pituitary rather than the mitochondria. The two act through different pathways; whether combining them adds benefit has not yet been studied in clinical trials.
BPC-157 and the Wolverine Stack target tissue repair, joint health, and systemic healing. Whether combining MOTS-c with healing peptides improves recovery has not yet been studied in clinical trials.
Selank and Semax work on neurotransmitter balance, focus, and stress resilience. The brain is one of the most metabolically demanding organs — whether MOTS-c changes the effect of cognitive peptides has not yet been studied.
More energy. Better recovery. A metabolism that finally works with you — not against you.
MOTS-c is prescribed and monitored from our Conshohocken clinic, in Montgomery County just outside Philadelphia. Bloodwork is drawn locally and visits are available in person or by telehealth across Pennsylvania.
YoungerMeMD · 125 East Elm Street, Suite 201, Conshohocken, PA 19428 · (215) 892-1230
Fill up the form below to get started
No provocation agent required. A urine test that checks for toxic metals standard labs do not routinely test for.
Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.
DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.
Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.
Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.
Estimates nutrient-related markers from DNA methylation with an at-home finger-prick kit. Not a diagnostic test; flagged results are confirmed with standard blood work.
Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Conditions We Identify
We use cookies from Google Analytics, Google Ads and Contentsquare to measure visits and ads. Nothing loads unless you click Accept. Cookie policy
